Mustang Bio, Inc. (MBIO)
NASDAQ·Healthcare·Biotechnology
$0.77
+1.03%
Mkt Cap $6.71M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 19, 2026 | — | — | — | -$5.50 | -$0.08 | +98.55% | — | — |
| Q4 2025 Nov 7, 2025 | — | — | — | — | -$0.07 | — | — | — |
| Q3 2025 Aug 8, 2025 | — | — | — | — | -$0.19 | — | — | — |
| Q2 2025 May 14, 2025 | — | — | — | — | -$0.05 | — | — | — |
| Q1 2025 Mar 24, 2025 | — | — | — | -$5.50 | -$37.95 | -590.00% | — | — |
| Q4 2024 Nov 8, 2024 | — | — | — | -$6.50 | -$2.00 | +69.23% | — | — |
| Q3 2024 Aug 13, 2024 | — | — | — | -$7.00 | -$12.00 | -71.43% | — | — |
| Q2 2024 May 15, 2024 | — | — | — | -$0.87 | -$23.00 | -2543.68% | — | — |
| Q1 2024 Mar 11, 2024 | — | $2.88M | — | -$84.00 | -$35.50 | +57.74% | — | — |
| Q4 2023 Nov 14, 2023 | — | — | — | -$94.00 | -$61.50 | +34.57% | — | — |
| Q3 2023 Aug 14, 2023 | — | — | — | -$103.50 | -$100.00 | +3.38% | — | — |
| Q2 2023 May 12, 2023 | — | — | — | -$142.50 | -$103.00 | +27.72% | — | — |
| Q1 2023 Mar 29, 2023 | — | — | — | -$142.43 | -$134.93 | +5.27% | — | — |
| Q4 2022 Nov 14, 2022 | — | — | — | -$149.93 | -$134.93 | +10.00% | — | — |
| Q3 2022 Aug 11, 2022 | — | — | — | -$157.42 | -$142.43 | +9.52% | — | — |
| Q2 2022 May 12, 2022 | — | — | — | -$134.93 | -$149.93 | -11.12% | — | — |
| Q1 2022 Mar 23, 2022 | — | — | — | -$157.42 | -$164.92 | -4.76% | — | — |
| Q4 2021 Nov 12, 2021 | — | — | — | -$134.93 | -$142.43 | -5.56% | — | — |
| Q3 2021 Aug 16, 2021 | — | — | — | -$149.93 | -$119.94 | +20.00% | — | — |
| Q2 2021 May 14, 2021 | — | — | — | -$149.93 | -$142.43 | +5.00% | — | — |